Trevi Therapeutics, Inc. Common Stock TRVI
$18.46
+1.71%
at last close
Analyst Consensus
- Consensus Rating
- Buy (12 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $24.08
- Implied Upside
- +30.5%
- Price Target Range
- $16.00 – $36.00
- Analysts (12 mo)
- 12
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-14 | Jones TradingDebanjana Chatterjee |
Maintains | Buy | $24 → $28 |
| 2026-08-07 | OppenheimerLeland Gershell |
Maintains | Outperform | $24 → $25 |
| 2026-08-07 | Cantor FitzgeraldJosh Schimmer |
Maintains | Overweight | $25 → $30 |
| 2026-07-21 | BMO CapitalConnor Murphy |
Initiates coverage on | Outperform | $36 |
| 2026-07-20 | B. Riley SecuritiesMayank Mamtani |
Maintains | Buy | $21 → $31 |
| 2026-07-20 | HC Wainwright & Co.Brandon Folkes |
Maintains | Buy | $21 → $24 |
| 2026-05-20 | NeedhamSerge Belanger |
Reiterates | Buy | $23 |
| 2026-05-06 | HC Wainwright & Co.Brandon Folkes |
Reiterates | Buy | $21 |
| 2026-05-06 | NeedhamSerge Belanger |
Maintains | Buy | $24 → $23 |
| 2026-04-17 | D. Boral CapitalJason Kolbert |
Maintains | Buy | $19 |
| 2026-03-19 | Jones TradingDebanjana Chatterjee |
Maintains | Buy | $25 → $24 |
| 2026-03-18 | Morgan StanleyJudah Frommer |
Maintains | Overweight | $19 → $18 |
| 2026-03-18 | D. Boral CapitalJason Kolbert |
Maintains | Buy | $19 |
| 2026-03-18 | NeedhamSerge Belanger |
Maintains | Buy | $22 → $24 |
| 2026-03-09 | D. Boral CapitalJason Kolbert |
Maintains | Buy | $19 |
| 2026-03-09 | HC Wainwright & Co.Brandon Folkes |
Reiterates | Buy | $21 |
| 2026-01-09 | HC Wainwright & Co.Brandon Folkes |
Reiterates | Buy | $21 |
| 2026-01-08 | D. Boral CapitalJason Kolbert |
Maintains | Buy | $19 |
| 2025-12-19 | StifelAnnabel Samimy |
Maintains | Buy | $15 → $18 |
| 2025-11-20 | Leerink PartnersFaisal Khurshid |
Maintains | Outperform | $13 → $16 |
| 2025-11-14 | D. Boral CapitalJason Kolbert |
Maintains | Buy | $19 |
| 2025-11-14 | OppenheimerLeland Gershell |
Maintains | Outperform | $23 → $24 |
| 2025-11-14 | Morgan StanleyJudah Frommer |
Maintains | Overweight | $18 → $19 |
| 2025-11-14 | Clear StreetKaveri Pohlman |
Maintains | Buy | $11 → $21 |
| 2025-08-21 | Morgan StanleyJudah Frommer |
Initiates coverage on | Overweight | $18 |
| 2025-08-08 | Raymond JamesRyan Deschner |
Maintains | Strong buy | $29 → $27 |
| 2025-08-08 | NeedhamSerge Belanger |
Maintains | Buy | $24 → $22 |
| 2025-07-01 | Cantor FitzgeraldJosh Schimmer |
Initiates coverage on | Overweight | $25 |
| 2025-06-02 | D. Boral CapitalJason Kolbert |
Maintains | Buy | $21 |
| 2025-05-28 | HC Wainwright & Co.Brandon Folkes |
Initiates coverage on | Buy | $21 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $18.46
- Market Cap
- $2.53 billion
- 52-Week Range
- $6.03 – $20.22
- Average Volume
- 2.26 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.